pharmaREADY

pharmaREADY is a division of TAKE Solutions (now part of Navitas Life Sciences) providing integrated regulatory compliance software for pharmaceutical and biopharmaceutical companies. The platform serves 200+ global biopharma companies with fully integrated, regulatory-compliant, web-based solutions.

Platform consists of four core modules: Document Management System (DMS), Electronic Common Technical Document (eCTD), Structured Product Labeling (SPL), and Tracking and Regulatory Management System (TRMS). These modules integrate to support both pre-marketing and post-marketing regulatory needs.

pharmaREADY eCTD has managed 250,000+ submissions to date across US FDA, EMA, Health Canada, and 12+ regulatory jurisdictions worldwide. Platform supports pharmaceuticals, biologics/biosimilars, medical devices, generic drugs, and animal health products.

Parent company TAKE Solutions updated the pharmaREADY Suite to complement end-to-end regulatory solutions for virtual and SMB life science companies, emphasizing the platform's focus on cost-effective compliance for smaller biopharma organizations.

pharmaREADY is exclusively focused on pharmaceutical and biopharmaceutical regulatory compliance. The platform serves 200+ global biopharma companies with integrated regulatory solutions for both pre-marketing and post-marketing needs.

The platform specifically targets virtual and SMB (small-to-medium biopharma) companies with cost-effective regulatory submission solutions. It supports pharmaceuticals, biologics/biosimilars, medical devices, generic drugs, and animal health products. Regulatory expertise covers US FDA, EMA, Health Canada, and 12+ global health authorities.

pharmaREADY eCTD has managed 250,000+ submissions to date. The vendor emphasises first-time-right submissions and compliance with ICH and regional guidelines. Customer names are undisclosed.

Revenue, funding and profitability are undisclosed. pharmaREADY is a division of TAKE Solutions, now part of Navitas Life Sciences, and financial information is not reported separately for the division. TAKE Solutions provides life sciences services and solutions globally.

The platform serves 200+ global biopharma companies and has managed 250,000+ regulatory submissions. The vendor markets the platform as having the "Lowest Total Cost of Ownership in the Industry," positioning it for cost-effective compliance at virtual and SMB life science companies.

The pharmaREADY platform consists of four integrated modules designed for regulatory compliance: Document Management System (DMS), Electronic Common Technical Document (eCTD), Structured Product Labeling (SPL), and Tracking and Regulatory Management System (TRMS).

The vendor emphasises integration between modules, claiming 40% faster submission completion when they are used together. All modules are web-based and regulatory-compliant, designed for multi-tenant SaaS deployment with an optional on-site installation. The vendor markets the suite on lower total cost of ownership, targeting virtual and SMB biopharma companies seeking cost-effective regulatory compliance.

No technology or integration partnerships are disclosed. The platform integrates internally between the pharmaREADY modules (DMS, eCTD, SPL, TRMS), with the vendor claiming seamless data flow between them.

Whether pharmaREADY draws on partnerships or infrastructure from parent company TAKE Solutions / Navitas Life Sciences is undisclosed. No industry affiliations, certification partnerships, or technology alliances are disclosed.

SaaS implementation includes standard deployment services with a timeline of less than one week. Support hours, languages and service-level agreements are undisclosed.

The platform is designed for rapid deployment with minimal implementation support required for SaaS customers. An on-site deployment option is also available. The implementation services for it are undisclosed. Training programmes, customer-success initiatives, user community and certification programmes are undisclosed. Whether professional services are available through parent company TAKE Solutions / Navitas Life Sciences is undisclosed.

Credibility rests on 250,000+ submissions managed to date across 200+ global biopharma companies. No certifications page is published for the platform itself. Parent company Navitas Life Sciences holds ISO/IEC 27001 and ISO 9001:2015, recorded on the pharmaready-dms solution profile; those are the parent's certificates, not ones pharmaREADY publishes for itself — unverified at product level, not absent. No analyst recognition or industry awards are disclosed.

Parent company TAKE Solutions / Navitas Life Sciences provides global life sciences services, lending enterprise backing. The vendor emphasises regulatory compliance across US FDA, EMA, Health Canada, and 12+ health authorities. No leadership-team information, thought-leadership content, or industry affiliations are disclosed.

The website provides basic product information but limited marketing content. No resource centre, whitepapers, case studies, or thought-leadership content is publicly available. Demo requests are available through a contact form; no free trial is disclosed.

No active social-media presence is evidenced. There is no press-release archive, news section, or blog on the pharmaREADY website. The most recent public information is a TAKE Solutions press release on pharmaREADY Suite updates. Online visibility is limited, with no presence on major review platforms (G2, Capterra, Gartner Peer Insights). Market positioning focuses on cost-effective compliance for SMB and virtual biopharma rather than broad market visibility.